One popular option, Weight Loss by Hers, is a holistic program personalized for you. The program features four pillars of ...

A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another ...

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...

Oklahoma Attorney General Gentner Drummond called on the FDA to take action against counterfeit weight-loss drug ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...

Oklahoma Attorney General Gentner Drummond Office on Wednesday confirmed action is in order with the Food and Drug Administration (FDA) addressing counterfeit weight-loss drug makers.

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

Dr. Kristen Kells, founder of Colorado Springs’ largest weight loss clinic, shared insights on GLP-1 drugs and explained why the Dr. Kells Method can offer better long-term ...

Zepbound may not be as widely known as its competitors, but the weight-loss drug may soon be more accessible than the rest.

Technology is transforming every aspect of our lives, and weight loss is no exception. From AI-driven meal plans to wearable fitness trackers, the future of weight loss is becoming more personalized, ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...